{"success":true,"data":{"pressRelease":{"id":"26991","rtpr_id":"nGNX2pfDl1","ticker":"VHI","exchange":"TSX","all_tickers":["VHI"],"title":"VitalHub Reports First Quarter 2026 Results","author":"Globe Newswire","published_at":"2026-05-07T21:55:00.208Z","article_body":"Annual Recurring Revenue (“ARR”)⁽¹⁾ up 34% YoY to $99.1 million\nTotal Revenue up 47% YoY to $31.9 million\nAdjusted EBITDA⁽¹⁾ up 42% YoY to $8.0 million\n\nTORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI)\n(OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today it has\nfiled its Interim Condensed Consolidated Financial Statements and Management's\nDiscussion and Analysis report for the three months ended March 31, 2026 with\nthe Canadian securities authorities. These documents may be viewed under the\nCompany’s profile at www.sedarplus.com.\n\n“We are pleased to report a strong start to the year, achieving 11% annual\norganic ARR⁽¹⁾ growth and 25% adjusted EBITDA as a percentage of\nrevenue⁽¹⁾,” said Dan Matlow, CEO of VitalHub. “Our recent\nacquisitions are supporting growth, and integration work is progressing well\nas we drive operational efficiency. We are pleased with first quarter billings\nand renewals across the entire organization. We continue to strengthen our\nbalance sheet and increase our capacity for acquisitions.”\n\nVitalHub’s quarterly investor conference call will take place on Friday, May\n8, 2026, at 9:00am EST. To register for the conference call please visit:\nhttps://us06web.zoom.us/webinar/register/WN_whpHyhutQhyBxYBelYnzDA#/registration\n\nFirst Quarter 2026 Highlights\n* ARR⁽¹⁾ as at March 31, 2026 was $99,078,809 as compared to $96,149,750\nat December 31, 2025, an increase of $2,929,059 or 3%.\nOver the previous quarter, ARR movement in Q1 2026 from Q4 2025 was\nattributable to the following:    * Organic growth of $2,729,378 or 3%.\n* Gain of $199,681 due to fluctuations in foreign exchange rates.\n    \n* ARR⁽¹⁾ as at March 31, 2026 was $99,078,809 as compared to $73,687,666\nat March 31, 2025, an increase of $25,391,143 or 34%.\nOver the previous year, ARR movement in Q1 2026 from Q1 2025 was attributable\nto the following:    * Organic growth of $8,182,967 or 11%.\n* Acquisition growth of $15,870,000 or 22%.\n* Gain of $1,338,176 due to fluctuations in foreign exchange rates.\n    \n* Revenue of $31,906,402 as compared to $21,674,966 in the equivalent prior\nyear period, an increase of $10,231,436 or 47%.\n* Gross profit as a percentage of revenue was 82% in Q1 2026 as compared to\n80% in the equivalent prior year period.\n* Net income before income taxes of $3,602,054 as compared to $1,487,413 in\nthe equivalent prior year period.\n* Net income of $2,355,117 as compared to $1,161,472 in the equivalent prior\nyear period.\n* EBITDA⁽¹⁾ of $6,528,302 as compared to $3,150,374 in the equivalent\nprior year period.\n* Adjusted EBITDA⁽¹⁾ of $7,989,761 or 25% of revenue as compared to\n$5,614,686 or 26% of revenue in the equivalent prior year period, an increase\nof $2,375,075 or 42%.\n* Cash and cash equivalents and short-term investments as at March 31, 2026\nwas $121,266,957 compared to $119,180,625 as at December 31, 2025.\n(1) Non-IFRS or supplementary financial measure.\n\n Selected Financial Information                                                                                                                              \n                                                                                                                                                             \n                                                            Three months ended                                                                               \n                                                            March 31, 2026         % Revenue               March 31, 2025        % Revenue      Change       \n                                                            $                                              $                                    %            \n Revenue                                                    31,906,402             100 %                   21,674,966            100%           47 %         \n                                                                                                                                                             \n Cost of sales                                              5,861,731              18 %                    4,230,673             20%            (39 %)       \n                                                                                                                                                             \n Gross profit                                               26,044,671             82 %                    17,444,293            80%            49 %         \n                                                                                                                                                             \n Operating expenses                                                                                                                                          \n General and administrative                                 5,764,464              18 %                    5,270,749             24%            (9 %)        \n Sales and marketing                                        3,015,286              9 %                     2,029,012             9%             (49 %)       \n Research and development                                   9,037,069              28 %                    5,220,183             24%            (73 %)       \n Depreciation of property and equipment                     138,842                0 %                     142,077               1%             2 %          \n Depreciation of right-of-use assets                        168,579                1 %                     119,896               1%             (41 %)       \n Share-based compensation                                   424,957                1 %                     765,400               4%             44 %         \n Deferred share-based compensation                          44,800                 0 %                     -                     0%             (100 %)      \n Foreign currency gain (loss)                               238,091                1 %                     (694,407    )         (3%)           134 %        \n                                                                                                                                                             \n Other expenses (income)                                                                                                                                     \n Amortization of intangible assets                          3,272,461              10 %                    1,921,394             9%             (70 %)       \n Business acquisition, restructuring and integration costs  991,702                3 %                     1,463,414             7%             32 %         \n Loss on change in fair value of contingent consideration   -                      0 %                     235,498               1%             100 %        \n Interest income (net of interest expense)                  (691,666     )         (2 %)                   (535,309    )         (2%)           29 %         \n Interest expense from lease liabilities                    38,032                 0 %                     14,903                0%             (155 %)      \n Loss on disposal of property and equipment                 -                      0 %                     4,070                 0%             100 %        \n                                                                                                                                                             \n Current and deferred income taxes (recoverable)            1,246,937              4 %                     325,941               2%             (283 %)      \n                                                                                                                                                             \n Net income (loss)                                          2,355,117              7 %                     1,161,472             5%             103 %        \n                                                                                                                                                             \n EBITDA                                                     6,528,302              20 %                    3,150,374             15%            107 %        \n                                                                                                                                                             \n Adjusted EBITDA                                            7,989,761              25 %                    5,614,686             26%            42 %         \n                                                                                                                                                             \n Annual recurring revenue                                   99,078,809                                     73,687,666                           34 %         \n                                                                                                                                                             \n Term licences, maintenance and support revenue             23,927,139             75 %                    18,343,566            85%            30 %         \n                                                                                                                                                             \n                                                            As at                                                                                            \n                                                            March 31, 2026         December 31, 2025                                                         \n                                                            $                      $                                                                         \n Cash and cash equivalents and short-term investments       121,266,957            119,180,625                                                               \n                                                                                                                                                             \n Deferred revenue                                           53,319,927             45,434,654                                                                \n\nAbout VitalHub\n\nVitalHub is a leading software company dedicated to empowering health and\nhuman services providers globally. VitalHub's comprehensive product suite\nincludes electronic health records, operational intelligence, and workforce\nautomation solutions that serve over 1,300 clients across the UK, Canada, and\nother geographies. The Company has a robust two-pronged growth strategy,\ntargeting organic opportunities within its product suite and pursuing an\naggressive M&A plan. VitalHub is headquartered in Toronto with over 700\nemployees globally, across key regions and the VitalHub Innovations Lab in Sri\nLanka. For more information about VitalHub (TSX:VHI) (OTCQX:VHIBF), please\nvisit www.vitalhub.com and LinkedIn\n(https://www.globenewswire.com/Tracker?data=Ag5u3t2Iu8bmLJPRZi0T-QyZMiVTJT_G0QbCt3zvZ5A79MqjgrQagXFj5jjKaCnC0ca0OKjr2YGZRbg5OpVnOjzLHDiwQkix1YJccTAwKmVfJOgb5ZgU10uQe4wP-Lpu).\n\nContact Information\n\nChristian Sgro, CPA, CA, CFA\nHead of IR and M&A Specialist\n(365) 363-6433\nchristian.sgro@vitalhub.com\n\nDan Matlow\nChief Executive Officer, Director\n(416) 727-9061\ndan.matlow@vitalhub.com\n\nCautionary Statement\n\nCertain statements contained in this news release may constitute\n\"forward-looking information\" or \"financial outlook\" within the meaning of\napplicable securities laws that involve known and unknown risks, uncertainties\nand other factors which may cause the actual results, performance or\nachievements to be materially different from any future results, performance\nor achievements expressed or implied by such forward-looking information or\nfinancial outlook. Often, but not always, forward-looking statements can be\nidentified by the use of words such as \"plans\", \"is expected\", \"expects\",\n\"scheduled\", \"intends\", \"contemplates\", \"anticipates\", \"believes\", \"proposes\"\nor variations (including negative variations) of such words and phrases, or\nstate that certain actions, events or results \"may\", \"could\", \"would\", \"might\"\nor \"will\" be taken, occur or be achieved. Such statements are based on the\ncurrent expectations of the management of each entity and are based on\nassumptions and subject to risks and uncertainties. Although the management of\neach entity believes that the assumptions underlying these statements are\nreasonable, they may prove to be incorrect. Although the Company has attempted\nto identify important factors that could cause actual actions, events or\nresults to differ materially from those described in forward-looking\nstatements, there may be other factors that cause actions, events or results\nto differ from those anticipated, estimated or intended. No forward-looking\nstatement can be guaranteed. Except as required by applicable securities laws,\nforward-looking statements speak only as of the date on which they are made\nand the Company undertakes no obligation to publicly update or revise any\nforward-looking statement, whether as a result of new information, future\nevents, or otherwise.\n\nNon-IFRS and Other Measures\n\nVitalHub uses certain financial and operating performance measures that\nmanagement believes provide meaningful information in assessing the Company's\nunderlying performance. Readers are cautioned that these measures may not have\na standardized meaning prescribed by IFRS and therefore may not be comparable\nto similar measures presented by other issuers. Accordingly, non-IFRS and\nsupplementary financial measures should not be considered in isolation or as a\nsubstitute for measures of performance prepared in accordance with IFRS.\nDefinitions, reconciliations, and an explanation of how the Company's non-IFRS\nand supplementary financial measures provide useful information to an investor\nare included below.\n\nAnnual recurring revenue (“ARR”)\n\nAnnual recurring revenue is a supplementary financial measure defined as\nannual renewable software licence fees and maintenance services. The Company\ndefines ARR as the recurring revenue that is expected based on yearly\nsubscriptions of the renewable software licence fees and maintenance services.\n\nEarnings before interest, taxation, depreciation, and amortization\n(“EBITDA”)\n\nEBITDA is a non-IFRS measure used by management to evaluate operational\nperformance. It is also a common measure that is reported on and used by\ninvestors in determining a company’s ability to incur and service debt, as\nwell as a valuation methodology. EBITDA is a non-IFRS measure and should not\nbe considered an alternative to operating income or net income (loss) in\nmeasuring the Company’s performance. The following chart reflects the\ncalculation of the Company’s EBITDA:\n\n                                        Three months ended                        \n                                        March 31, 2026       March 31, 2025       \n                                        $                    $                    \n Net income                             2,355,117            1,161,472            \n Add: Interest                          (653,634   )         (520,406   )         \n Add: Depreciation and amortization     3,579,882            2,183,367            \n Add: Current and deferred tax expense  1,246,937            325,941              \n EBITDA                                 6,528,302            3,150,374            \n\nAdjusted EBITDA and Adjusted EBITDA as a percentage of revenue\n\nAdjusted EBITDA is a non-IFRS measure used by management to evaluate cash\nflows and the Company’s ability to service debt. Adjusted EBITDA is a\nnon-IFRS measure and should not be considered an alternative to operating\nincome or net income (loss) in measuring the Company’s performance. Adjusted\nEBITDA as a percentage of revenue expresses Adjusted EBITDA as a percentage of\ntotal revenue. The following chart reflects the Company’s calculation of\nAdjusted EBITDA:\n\n                                                                 Three months ended                        \n                                                                 March 31, 2026       March 31, 2025       \n                                                                 $                    $                    \n EBITDA                                                          6,528,302            3,150,374            \n Add: Share and deferred-based compensation expense              469,757              765,400              \n Add: Business acquisition, restructuring and integration costs  991,702              1,463,414            \n Add: Loss on change in fair value of contingent consideration   -                    235,498              \n Adjusted EBITDA                                                 7,989,761            5,614,686            \n\n\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/fae8da93-7d5e-4eb4-9121-d724c8555bce)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX2pfDl1","title":"VitalHub Reports First Quarter 2026 Results","author":"Globe Newswire","ticker":"VHI","created":"2026-05-07T21:55:00.208Z","tickers":["VHI"],"exchange":"TSX","article_body":"Annual Recurring Revenue (“ARR”)⁽¹⁾ up 34% YoY to $99.1 million\nTotal Revenue up 47% YoY to $31.9 million\nAdjusted EBITDA⁽¹⁾ up 42% YoY to $8.0 million\n\nTORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI)\n(OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today it has\nfiled its Interim Condensed Consolidated Financial Statements and Management's\nDiscussion and Analysis report for the three months ended March 31, 2026 with\nthe Canadian securities authorities. These documents may be viewed under the\nCompany’s profile at www.sedarplus.com.\n\n“We are pleased to report a strong start to the year, achieving 11% annual\norganic ARR⁽¹⁾ growth and 25% adjusted EBITDA as a percentage of\nrevenue⁽¹⁾,” said Dan Matlow, CEO of VitalHub. “Our recent\nacquisitions are supporting growth, and integration work is progressing well\nas we drive operational efficiency. We are pleased with first quarter billings\nand renewals across the entire organization. We continue to strengthen our\nbalance sheet and increase our capacity for acquisitions.”\n\nVitalHub’s quarterly investor conference call will take place on Friday, May\n8, 2026, at 9:00am EST. To register for the conference call please visit:\nhttps://us06web.zoom.us/webinar/register/WN_whpHyhutQhyBxYBelYnzDA#/registration\n\nFirst Quarter 2026 Highlights\n* ARR⁽¹⁾ as at March 31, 2026 was $99,078,809 as compared to $96,149,750\nat December 31, 2025, an increase of $2,929,059 or 3%.\nOver the previous quarter, ARR movement in Q1 2026 from Q4 2025 was\nattributable to the following:    * Organic growth of $2,729,378 or 3%.\n* Gain of $199,681 due to fluctuations in foreign exchange rates.\n    \n* ARR⁽¹⁾ as at March 31, 2026 was $99,078,809 as compared to $73,687,666\nat March 31, 2025, an increase of $25,391,143 or 34%.\nOver the previous year, ARR movement in Q1 2026 from Q1 2025 was attributable\nto the following:    * Organic growth of $8,182,967 or 11%.\n* Acquisition growth of $15,870,000 or 22%.\n* Gain of $1,338,176 due to fluctuations in foreign exchange rates.\n    \n* Revenue of $31,906,402 as compared to $21,674,966 in the equivalent prior\nyear period, an increase of $10,231,436 or 47%.\n* Gross profit as a percentage of revenue was 82% in Q1 2026 as compared to\n80% in the equivalent prior year period.\n* Net income before income taxes of $3,602,054 as compared to $1,487,413 in\nthe equivalent prior year period.\n* Net income of $2,355,117 as compared to $1,161,472 in the equivalent prior\nyear period.\n* EBITDA⁽¹⁾ of $6,528,302 as compared to $3,150,374 in the equivalent\nprior year period.\n* Adjusted EBITDA⁽¹⁾ of $7,989,761 or 25% of revenue as compared to\n$5,614,686 or 26% of revenue in the equivalent prior year period, an increase\nof $2,375,075 or 42%.\n* Cash and cash equivalents and short-term investments as at March 31, 2026\nwas $121,266,957 compared to $119,180,625 as at December 31, 2025.\n(1) Non-IFRS or supplementary financial measure.\n\n Selected Financial Information                                                                                                                              \n                                                                                                                                                             \n                                                            Three months ended                                                                               \n                                                            March 31, 2026         % Revenue               March 31, 2025        % Revenue      Change       \n                                                            $                                              $                                    %            \n Revenue                                                    31,906,402             100 %                   21,674,966            100%           47 %         \n                                                                                                                                                             \n Cost of sales                                              5,861,731              18 %                    4,230,673             20%            (39 %)       \n                                                                                                                                                             \n Gross profit                                               26,044,671             82 %                    17,444,293            80%            49 %         \n                                                                                                                                                             \n Operating expenses                                                                                                                                          \n General and administrative                                 5,764,464              18 %                    5,270,749             24%            (9 %)        \n Sales and marketing                                        3,015,286              9 %                     2,029,012             9%             (49 %)       \n Research and development                                   9,037,069              28 %                    5,220,183             24%            (73 %)       \n Depreciation of property and equipment                     138,842                0 %                     142,077               1%             2 %          \n Depreciation of right-of-use assets                        168,579                1 %                     119,896               1%             (41 %)       \n Share-based compensation                                   424,957                1 %                     765,400               4%             44 %         \n Deferred share-based compensation                          44,800                 0 %                     -                     0%             (100 %)      \n Foreign currency gain (loss)                               238,091                1 %                     (694,407    )         (3%)           134 %        \n                                                                                                                                                             \n Other expenses (income)                                                                                                                                     \n Amortization of intangible assets                          3,272,461              10 %                    1,921,394             9%             (70 %)       \n Business acquisition, restructuring and integration costs  991,702                3 %                     1,463,414             7%             32 %         \n Loss on change in fair value of contingent consideration   -                      0 %                     235,498               1%             100 %        \n Interest income (net of interest expense)                  (691,666     )         (2 %)                   (535,309    )         (2%)           29 %         \n Interest expense from lease liabilities                    38,032                 0 %                     14,903                0%             (155 %)      \n Loss on disposal of property and equipment                 -                      0 %                     4,070                 0%             100 %        \n                                                                                                                                                             \n Current and deferred income taxes (recoverable)            1,246,937              4 %                     325,941               2%             (283 %)      \n                                                                                                                                                             \n Net income (loss)                                          2,355,117              7 %                     1,161,472             5%             103 %        \n                                                                                                                                                             \n EBITDA                                                     6,528,302              20 %                    3,150,374             15%            107 %        \n                                                                                                                                                             \n Adjusted EBITDA                                            7,989,761              25 %                    5,614,686             26%            42 %         \n                                                                                                                                                             \n Annual recurring revenue                                   99,078,809                                     73,687,666                           34 %         \n                                                                                                                                                             \n Term licences, maintenance and support revenue             23,927,139             75 %                    18,343,566            85%            30 %         \n                                                                                                                                                             \n                                                            As at                                                                                            \n                                                            March 31, 2026         December 31, 2025                                                         \n                                                            $                      $                                                                         \n Cash and cash equivalents and short-term investments       121,266,957            119,180,625                                                               \n                                                                                                                                                             \n Deferred revenue                                           53,319,927             45,434,654                                                                \n\nAbout VitalHub\n\nVitalHub is a leading software company dedicated to empowering health and\nhuman services providers globally. VitalHub's comprehensive product suite\nincludes electronic health records, operational intelligence, and workforce\nautomation solutions that serve over 1,300 clients across the UK, Canada, and\nother geographies. The Company has a robust two-pronged growth strategy,\ntargeting organic opportunities within its product suite and pursuing an\naggressive M&A plan. VitalHub is headquartered in Toronto with over 700\nemployees globally, across key regions and the VitalHub Innovations Lab in Sri\nLanka. For more information about VitalHub (TSX:VHI) (OTCQX:VHIBF), please\nvisit www.vitalhub.com and LinkedIn\n(https://www.globenewswire.com/Tracker?data=Ag5u3t2Iu8bmLJPRZi0T-QyZMiVTJT_G0QbCt3zvZ5A79MqjgrQagXFj5jjKaCnC0ca0OKjr2YGZRbg5OpVnOjzLHDiwQkix1YJccTAwKmVfJOgb5ZgU10uQe4wP-Lpu).\n\nContact Information\n\nChristian Sgro, CPA, CA, CFA\nHead of IR and M&A Specialist\n(365) 363-6433\nchristian.sgro@vitalhub.com\n\nDan Matlow\nChief Executive Officer, Director\n(416) 727-9061\ndan.matlow@vitalhub.com\n\nCautionary Statement\n\nCertain statements contained in this news release may constitute\n\"forward-looking information\" or \"financial outlook\" within the meaning of\napplicable securities laws that involve known and unknown risks, uncertainties\nand other factors which may cause the actual results, performance or\nachievements to be materially different from any future results, performance\nor achievements expressed or implied by such forward-looking information or\nfinancial outlook. Often, but not always, forward-looking statements can be\nidentified by the use of words such as \"plans\", \"is expected\", \"expects\",\n\"scheduled\", \"intends\", \"contemplates\", \"anticipates\", \"believes\", \"proposes\"\nor variations (including negative variations) of such words and phrases, or\nstate that certain actions, events or results \"may\", \"could\", \"would\", \"might\"\nor \"will\" be taken, occur or be achieved. Such statements are based on the\ncurrent expectations of the management of each entity and are based on\nassumptions and subject to risks and uncertainties. Although the management of\neach entity believes that the assumptions underlying these statements are\nreasonable, they may prove to be incorrect. Although the Company has attempted\nto identify important factors that could cause actual actions, events or\nresults to differ materially from those described in forward-looking\nstatements, there may be other factors that cause actions, events or results\nto differ from those anticipated, estimated or intended. No forward-looking\nstatement can be guaranteed. Except as required by applicable securities laws,\nforward-looking statements speak only as of the date on which they are made\nand the Company undertakes no obligation to publicly update or revise any\nforward-looking statement, whether as a result of new information, future\nevents, or otherwise.\n\nNon-IFRS and Other Measures\n\nVitalHub uses certain financial and operating performance measures that\nmanagement believes provide meaningful information in assessing the Company's\nunderlying performance. Readers are cautioned that these measures may not have\na standardized meaning prescribed by IFRS and therefore may not be comparable\nto similar measures presented by other issuers. Accordingly, non-IFRS and\nsupplementary financial measures should not be considered in isolation or as a\nsubstitute for measures of performance prepared in accordance with IFRS.\nDefinitions, reconciliations, and an explanation of how the Company's non-IFRS\nand supplementary financial measures provide useful information to an investor\nare included below.\n\nAnnual recurring revenue (“ARR”)\n\nAnnual recurring revenue is a supplementary financial measure defined as\nannual renewable software licence fees and maintenance services. The Company\ndefines ARR as the recurring revenue that is expected based on yearly\nsubscriptions of the renewable software licence fees and maintenance services.\n\nEarnings before interest, taxation, depreciation, and amortization\n(“EBITDA”)\n\nEBITDA is a non-IFRS measure used by management to evaluate operational\nperformance. It is also a common measure that is reported on and used by\ninvestors in determining a company’s ability to incur and service debt, as\nwell as a valuation methodology. EBITDA is a non-IFRS measure and should not\nbe considered an alternative to operating income or net income (loss) in\nmeasuring the Company’s performance. The following chart reflects the\ncalculation of the Company’s EBITDA:\n\n                                        Three months ended                        \n                                        March 31, 2026       March 31, 2025       \n                                        $                    $                    \n Net income                             2,355,117            1,161,472            \n Add: Interest                          (653,634   )         (520,406   )         \n Add: Depreciation and amortization     3,579,882            2,183,367            \n Add: Current and deferred tax expense  1,246,937            325,941              \n EBITDA                                 6,528,302            3,150,374            \n\nAdjusted EBITDA and Adjusted EBITDA as a percentage of revenue\n\nAdjusted EBITDA is a non-IFRS measure used by management to evaluate cash\nflows and the Company’s ability to service debt. Adjusted EBITDA is a\nnon-IFRS measure and should not be considered an alternative to operating\nincome or net income (loss) in measuring the Company’s performance. Adjusted\nEBITDA as a percentage of revenue expresses Adjusted EBITDA as a percentage of\ntotal revenue. The following chart reflects the Company’s calculation of\nAdjusted EBITDA:\n\n                                                                 Three months ended                        \n                                                                 March 31, 2026       March 31, 2025       \n                                                                 $                    $                    \n EBITDA                                                          6,528,302            3,150,374            \n Add: Share and deferred-based compensation expense              469,757              765,400              \n Add: Business acquisition, restructuring and integration costs  991,702              1,463,414            \n Add: Loss on change in fair value of contingent consideration   -                    235,498              \n Adjusted EBITDA                                                 7,989,761            5,614,686            \n\n\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/fae8da93-7d5e-4eb4-9121-d724c8555bce)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-05-07T21:55:00.259051021Z","server_sent_at_ms":1778190900259},"received_at":"2026-05-07T21:55:00.324Z","source_url":null},"analysis":{"id":"21116","press_release_id":"26991","analysis_json":{"industry":{"label":"Software","sector":"Information Technology"},"redFlags":[],"eventType":"earnings","narrative":"VitalHub reported Q1 2026 results showing a 47% YoY increase in total revenue to $31.9 million and a 34% YoY increase in ARR to $99.1 million.\n\nAdjusted EBITDA rose by 42% to $8.0 million, with a 25% margin of revenue, while gross profit as a percentage of revenue was 82%.\n\nThe company highlighted organic and acquisition-driven growth, as well as a strong balance sheet with $121.3 million in cash and short-term investments.","sentiment":"bullish","agentHooks":{"shouldPost":true,"suggestedAngle":"Strong Q1 results with 47% revenue growth and 34% ARR increase, supported by recent acquisitions."},"keyFigures":{"revenue":31906402,"revenueYoy":"47%","customDimensions":{"arr":99078809,"ebitda":6528302,"net_income":2355117,"adjusted_ebitda":7989761,"gross_profit_percentage":"82%","net_income_before_taxes":3602054,"adjusted_ebitda_percentage":"25%"}},"quotedText":"We are pleased to report a strong start to the year, achieving 11% annual organic ARR growth and 25% adjusted EBITDA as a percentage of revenue.","namedEntities":{"people":[{"name":"Dan Matlow","role":"CEO"},{"name":"Christian Sgro","role":"Head of IR and M&A Specialist"}],"products":["Annual recurring revenue","Adjusted EBITDA","EBITDA"],"companies":[{"name":"Vitalhub Corp.","ticker":"VHI"},{"name":"GlobeNewswire, Inc."}],"dollarAmounts":[{"amount":"$99.1 million","context":"ARR"},{"amount":"$31.9 million","context":"Total Revenue"},{"amount":"$8.0 million","context":"Adjusted EBITDA"},{"amount":"$2.355 million","context":"Net income"},{"amount":"$3.602 million","context":"Net income before income taxes"},{"amount":"$6.528 million","context":"EBITDA"}]},"materialImpact":{"score":4,"reasoning":"Strong YoY revenue growth of 47% and ARR growth of 34% to $99.1 million. Adjusted EBITDA increased by 42% to $8.0 million. The company also highlighted recent acquisitions contributing to growth, indicating a strategic expansion."},"tickerRelevance":{"others":[],"primary":"VHI"},"globalImportance":45,"audienceRelevance":55,"eventTypeSecondary":["m_and_a"],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"earnings","sectorWeight":"Information Technology","audienceRelevance":"software industry with global client base"}},"event_type":"earnings","event_type_secondary":["m_and_a"],"sentiment":"bullish","material_impact_score":4,"narrative":"VitalHub reported Q1 2026 results showing a 47% YoY increase in total revenue to $31.9 million and a 34% YoY increase in ARR to $99.1 million.\n\nAdjusted EBITDA rose by 42% to $8.0 million, with a 25% margin of revenue, while gross profit as a percentage of revenue was 82%.\n\nThe company highlighted organic and acquisition-driven growth, as well as a strong balance sheet with $121.3 million in cash and short-term investments.","key_figures":{"revenue":31906402,"revenueYoy":"47%","customDimensions":{"arr":99078809,"ebitda":6528302,"net_income":2355117,"adjusted_ebitda":7989761,"gross_profit_percentage":"82%","net_income_before_taxes":3602054,"adjusted_ebitda_percentage":"25%"}},"named_entities":{"people":[{"name":"Dan Matlow","role":"CEO"},{"name":"Christian Sgro","role":"Head of IR and M&A Specialist"}],"products":["Annual recurring revenue","Adjusted EBITDA","EBITDA"],"companies":[{"name":"Vitalhub Corp.","ticker":"VHI"},{"name":"GlobeNewswire, Inc."}],"dollarAmounts":[{"amount":"$99.1 million","context":"ARR"},{"amount":"$31.9 million","context":"Total Revenue"},{"amount":"$8.0 million","context":"Adjusted EBITDA"},{"amount":"$2.355 million","context":"Net income"},{"amount":"$3.602 million","context":"Net income before income taxes"},{"amount":"$6.528 million","context":"EBITDA"}]},"model_name":"Qwen/Qwen3-32B-AWQ","prompt_hash":"sha256:f66160e0fe5301b2","schema_hash":"sha256:12363694422af5d9","created_at":"2026-05-08T05:23:27.809Z","global_importance":45,"audience_relevance":55,"importance_components":{"tickerTier":"mid-cap","eventGravity":"earnings","sectorWeight":"Information Technology","audienceRelevance":"software industry with global client base"}},"durationMs":23399,"modelName":"glm-4.7"}}